Search result for: T-cell Immunotherapy

June 2026

T-cell Immunotherapy Market Size, Share and Trends 2026 to 2035

  • Report Code : 6994
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.

September 2026

T-cell Therapy Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 3205
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global T-cell therapy market size is reached at USD 13.99 billion in 2026 and it is expected to hit around USD 196.21 billion by 2035 with a CAGR of 34.27%.

September 2026

Immunotherapy Drugs Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Clinical Trial Trends, Market Share, and Demand Forecast

  • Report Code : 1472
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global immunotherapy drugs market size was valued at USD 376.22 billion in 2026 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.

September 2026

Cancer Immunotherapy Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Clinical Trial Trends, Market Share, and Demand Forecast

  • Report Code : 1394
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The cancer immunotherapy market size is calculated at USD 151.26 billion in 2026 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.

September 2026

Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Key Companies, Company Product Portfolio, Hospital Procurement Trends, Manufacturing Capacity, Sales Performance, Regulatory Approvals, Company Market Share, and Forecast

  • Report Code : 4767
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.

September 2026

Radioimmunotherapy Market Trends, Leading Companies, Company Revenue / Sales Performance, Procedure Volume, Healthcare Spending, Technology Adoption, Reimbursement Analysis, Competitive Landscape, and Growth Outlook

  • Report Code : 5012
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global radioimmunotherapy market size was evaluated at USD 3.65 billion in 2026 and is expected to attain around USD 14.36 billion by 2035, with a CAGR of 16.46%.

September 2026

T-Cell Engagers Market Size, Companies, Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 8262
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The t-cell engagers market was valued at USD 8.89 billion in 2026, with leading companies including Amgen Inc., AstraZeneca plc, Roche (Genentech), Johnson & Johnson (Janssen).

September 2026

U.S. CAR T-Cell Therapy Market Size, Companies, Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 8477
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The U.S. CAR T-cell therapy market size stood at USD 2,684.84 million in 2026, with major U.S. CAR T-cell therapy market companies including Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc.

September 2026

AI in Cancer Immunotherapy Drugs Market Size, Companies, Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 8626
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The AI in cancer immunotherapy drugs market reached USD 3.52 billion in 2026, featuring leading AI in cancer immunotherapy drugs market companies such as Exscientia, Insilico Medicine.

July 2026

CAR T-Cell Therapy Market Size, Share and Trends 2026 to 2035

  • Report Code : 2545
  • Published : July 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.

June 2026

Engineered TCR (T-Cell Receptor) Therapy Market Size, Share and Trends 2026 to 2035

  • Report Code : 6967
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.

For Any Query

Please drop a mail to the Precedence Research team for your queries

Contact Us

Categories

Quick Contact

call +1 650 460 3308 call +61 485 981 310
+91 87933 22019 call +44 7383 092 044 mail sales@precedenceresearch.com

Connect with us now; your solution awaits on the other side!

Contact Us